#1
|
|||
|
|||
Ïåïòèäíûå áèîðåãóëÿòîðû
Ïðîøó ïðîêîììåíòèðîâàòü óâàæàåìûõ âðà÷åé íèæåñëåäóþùóþ èíôîðìàöèþ:
 Ïåòåðáóðãñêîì èíñòèòóòåò ãåðîíòîëîãèè ðàçðàáîòàí êîìïëåêñ ïåïòèäîâ, êîòîðûé ïî óòâåðæäåíèþ ðàçðàáîò÷èêîâ îìîëàæèâàåò êëåòêè ÷åëîâå÷åñêîãî òåëà; îñóùåñòâëÿåò çàùèòíîå âîçäåéñòâèå; ïîâûøàåò óñòîé÷èâîñòü êëåòîê ê ãèïîêñèè, äåéñòâèþ òîêñèíîâ è èíûõ ïîâðåæäàþùèõ ôàêòîðîâ; íîðìàëèçóåò îáìåí âåùåñòâ â òêàíÿõ, óâåëè÷èâàåò ýôôåêòèâíîñòü ïðîöåññîâ óñâîåíèÿ òêàíÿìè ïèòàòåëüíûõ âåùåñòâ è âûâåäåíèÿ ïðîäóêòîâ ìåòàáîëèçìà; ïîëîæèòåëüíî âëèÿåò íà àêòèâíîñòü îðãàíîâ è òêàíåé â íîðìàëüíûõ è ïàòîëîãè÷åñêèõ óñëîâèÿõ, ïîääåðæèâàÿ íà ôèçèîëîãè÷åñêîì óðîâíå ÷èñëåííîñòü çðåëûõ, ôóíêöèîíàëüíî àêòèâíûõ êëåòîê, à òàêæå îáìåí âåùåñòâ â íèõ; îïòèìèçèðóþò ïðîöåññû âîññòàíîâëåíèÿ îðãàíîâ è òêàíåé. |
#2
|
|||
|
|||
Îáìàí. Íåâçèðàÿ íà ññûëêè.
__________________
Ñ óâàæåíèåì, Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî |
#3
|
|||
|
|||
À íå ìîãëè áû Âû äàòü áîëåå ðàñøèðåííûé îòâåò?
Âíåøíå, äëÿ íåñïåöèàëèñòà âñ¸ âûãëÿäèò ïðèâëåêàòåëüíî. Âåäü íàñêîëüêî ÿ çíàþ, ñóùåñòâóþò ãîðìîíû ïåïòèäíîé ïðèðîäû - ïî÷åìó èõ íåëüçÿ ñèíòåçèðîâàòü è ââåñòè â îðãàíèçì? Ñîðè çà ññûëêè - íå óñïåë ïîíÿòü, ÷òî íà ýòîì ôîðóìå îíè íåóìåñòíû. |
#4
|
|||
|
|||
Ïðàâèëüíî:
êîíêðåòíàÿ áîëåçíü + êîíêðåòíûé ïðåïàðàò â òàêîé-òî äîçå = òàêîé-òî ýôôåêò ó òàêîãî-òî ïðîöåíòà ïàöèåíòîâ. Íåïðàâèëüíî: óëó÷øàåò îáìåí, ïèòàíèå, ñïîñîáñòâóåò, î÷åíü õîðîøèé, ïîêóïàéòå íàøèõ ñëîíîâ. |
#5
|
|||
|
|||
Äà, Âû ïðàâû, íî ÿ âåäü ïðèâ¸ë ðåêëàìíûé ñëîãàí.
Ðàçðåøèòå ÿ ïðèâåäó âûäåðæêó èç îïèñàíèÿ èññëåäîâàíèé, êîòîðîå áîëåå ñîîòâåòñòâóåò ñòðîãîñòè íàó÷íîãî ïîäõîäà: "Òèìàëèí âûäåëåí â 1974 ã. Â. Ã. Ìîðîçîâûì è Â. X. Õàâèíñîíîì èç âèëî÷êîâîé æåëåçû òåëÿò. Òêàíü òèìóñà îáðàáàòûâàëè àöåòîíîì, ãîìîãåíèçèðîâàëè, ýêñòðàãèðîâàëè 3 %-íîé óêñóñíîé êèñëîòîé â ïðèñóòñòâèè õëîðèäà öèíêà íà ïðîòÿæåíèè 72 ÷ è ê ñóïåðíàòàíòó äîáàâëÿëè àöåòîí. Îñàäîê ìíîãîêðàòíî ïðîìûâàëè àöåòîíîì è âûñóøèâàëè. Ýòîò êîìïëåêñ ïîëèïåïòèäîâ â äàëüíåéøåì ïîäâåðãàëñÿ äîïîëíèòåëüíîé î÷èñòêå, èç íåãî óäàëÿëè òðóäíîðàñòâîðèìûå ôðàêöèè (Ìîðîçîâ è äð., 1977). Âûäåëåííûé êîìïëåêñ ïîëó÷èë íàèìåíîâàíèå òèìàëèí è áûë ðàçðåøåí Ôàðìàêîëîãè÷åñêèì êîìèòåòîì äëÿ êëèíè÷åñêîãî ïðèìåíåíèÿ â 1977 ã. Ïðè ýêñïåðèìåíòàëüíîì èçó÷åíèè îáíàðóæåí øèðîêèé ñïåêòð ôàðìàêîëîãè÷åñêîé àêòèâíîñòè òèìàëèíà, ïðîÿâëÿþùèéñÿ â âîññòàíîâëåíèè ðÿäà ôèçèîëîãè÷åñêèõ ôóíêöèé îðãàíèçìà: èììóíîëîãè÷åñêîé ðåàêòèâíîñòè, ãåìîïîýçà, ãåìîñòàçà, íåéðîýíäîêðèííîé ðåãóëÿöèè è äð. Ïåïòèäû òèìóñà îáëàäàþò âûñîêîé èçáèðàòåëüíîñòüþ äåéñòâèÿ, ýôôåêòèâíû â î÷åíü ìàëûõ äîçàõ, ëåãêî âûâîäÿòñÿ èç îðãàíèçìà è, êàê ïðàâèëî, íå âûçûâàþò îòðèöàòåëüíûõ ïîáî÷íûõ ýôôåêòîâ. Ýêñïåðèìåíòàëüíûå äàííûå. Èììóíîìîäóëèðóþùåå âëèÿíèå. Ââåäåíèå òèìàëèíà ìîðñêèì ñâèíêàì îêàçûâàåò ìîäóëèðóþùåå äåéñòâèå êàê íà ëèìôîèäíûé, òàê è íà ðåòèêóëîýïèòåëèàëüíûé êîìïîíåíòû âèëî÷êîâîé æåëåçû. Ïðèýòîì èçìåíÿåòñÿ ñòðóêòóðà òèìóñà çà ñ÷åò ïðîëèôåðàöèè è äèôôåðåíöèðîâàëè ëèìôîèäíûõ ýëåìåíòîâ è óâåëè÷åíèÿ â íåì ÷èñëà çðåëûõ (ìàëûõ) ëèìôîöèòîâ (Õìåëüíèöêèé è äð., 1975). Ïðè ââåäåíèè èíòàêòíûì êðûñàì íà ïðîòÿæåíèè 2 íåäåëü òèìàëèíà ó íèõ èçìåíÿþòñÿ ïîêàçàòåëè èììóíèòåòà è íåñïåöèôè÷åñêîé ðåçèñòåíòíîñòè îðãàíèçìà: óìåíüøàåòñÿ òèòð êîìïëåìåíòà, óâåëè÷èâàåòñÿ áàêòåðèöèäíàÿ àêòèâíîñòü ñûâîðîòêè è ñîäåðæàíèå áåòà-ëèçèíîâ." è ò.ä. - íå ðèñêóþ ïðèâîäèòü áîëåå îáøèðíóþ öèòàòó. Ïðîøó ìåíÿ ïîíÿòü - ÿ âîâñå íå ñîáèðàþñü ðåêëàìèðîâàòü èõ ïðîäóêöèþ, íî õîòåë áû ñ ïîìîùüþ ñïåöèàëèñòîâ ôîðóìà ïîíÿòü - â ÷¸ì ïðîêîë äàííîãî ïîäõîäà. |
#6
|
|||
|
|||
Öèòàòà:
1. åñëè ïðåïàðàò, íàïðèìåð, òîðìîçèò ðàçâèòèå ðàêîâîé îïóõîëè, òî îí "ïðàâèëüíûé" (ñ ýòèì âñå ÿñíî), îäíàêî, 2. åñëè ïðè ïðîôèëàêòè÷åñêîì ïðèåìå äðóãîãî ïðåïàðàòà îïóõîëåé âîîáùå íå âîçíèêàåò, òî îí óêàçàííîìó êðèòåðèþ "ïðàâèëüíîñòè" íå óäîâëåòâîðÿåò è äîëæåí "go to #4". Êàæåòñÿ, çäåñü ÷òî-òî íå òàê. ß â êîíöåïòóàëüíîì ïëàíå ñïðàøèâàþ, ïîýòîìó íå íàäî òðåáîâàòü êîíêðåòíûõ ïðèìåðîâ. ÏÐÈÍÖÈÏÈÀËÜÍÀß âîçìîæíîñòü òàêîãî ðîäà ïðåïàðàòîâ ñîìíåíèÿ, êàê áóäòî, íå âûçûâàåò è õî÷åòñÿ ïîíÿòü, êàê îíè ñìîãóò âíåäðèòüñÿ ïðè îáîçíà÷åííîì âûøå ïîäõîäå? |
#7
|
||||
|
||||
Ïðèíöèïèàëüíî âñå åùå ïðîùå - â ãðóïïå ÐÈÑÊÀ ïðîâîäèòñÿ ïðîôèëàêòèçèðóþùåå âìåøàòåëüñâî è îöåíèâàåòñÿ åãî ýôôåêòèâíîñòü - äåëîâ-òî
Íïðì , â ãðóïïå ðèñêà ÌÝÍ2 ïðîâîäèòñÿ ãåíåòè÷åñèêé ñêðèíèíã áëèæàéøèõ ðîäñòâåííèêîâ ïðîáàíäà è ïðè íàëè÷èè îïðåäëåííûõ ìóòàöé ïðîâîäÿòñÿ îïðåäåëåííûå âìåøàòåëüñâà  ãðóïïå ðèñêà ñíèæåíèÿ IQ ó ïîòîìñòâà ïðîâîäèòñÿ èîäíàÿ ãðóïïîâàÿ ïðîôèëàêòèêà ó áåðåìåííûõ è êîðìÿùèõ è ïîïóëÿöèîííàÿ è âñåõ îñòàëüíûõ  ãðóïïàõ ðèñêà ñìåðòè îò ãðèïïà ïðîâîäèòñÿ âàêöèíàöèÿ, ïðè ê àòàñòðîôå íà àòîìíîé ÀÑ ïðîâîäèòñÿ ïðîôèëàòêèêà ôàðìàêîëîãè÷ñêèìè äîçàìè èîäû â ãðóïïàõ äî 45 ëåò, à ïîòðåáëÿé âñå íàøå íàñåëåíèå èîäèðîâàííóþ ñîëü , ðàêîâ ×åðíîáûëüñêèõ ó äåòåé áûëî áû ââ 4 ðàçà ìåíüøå - òàê ÷òî äðåâî æèçíè çåëåíååò ..
__________________
Ã.À. Ìåëüíè÷åíêî |
|
#8
|
|||
|
|||
Öèòàòà:
À Âû, ïîäîçðåâàþ, èìååòå ââèäó óòâåðæäåíèÿ ïðîäàâöîâ î òîì, ÷òî "òå, êòî ïü¸ò íàøå **** - íå áîëåþò âîîáùå". |
#9
|
|||
|
|||
Öèòàòà:
Öèòàòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):233-40. Peptides of pineal gland and thymus prolong human life. Khavinson VKh, Morozov VG. OBJECTIVES AND DESIGN: Researchers of the St. Petersburg Institute of Bioregulation and Gerontology of the North-Western Branch of the Russian Academy of Medical Sciences and the Institute of Gerontology of the Ukrainian Academy of Medical Sciences (Kiev) clinically assessed the geroprotective effects of thymic (Thymalin) and pineal (Epithalamin) peptide bioregulators in 266 elderly and older persons during 6-8 years. The bioregulators were applied for the first 2-3 years of observation. RESULTS: The obtained results convincingly showed the ability of the bioregulators to normalize the basic functions of the human organism, i.e. to improve the indices of cardiovascular, endocrine, immune and nervous systems, homeostasis and metabolism. Homeostasis restoration was accompanied by a 2.0-2.4-fold decrease in acute respiratory disease incidence, reduced incidence of the clinical manifestations of ischemic heart disease, hypertension disease, deforming osteoarthrosis and osteoporosis as compared to the control. Such a significant improvement in the health state of the peptide-treated patients correlated with decreased mortality rate during observation: 2.0-2.1-fold in the Thymalin-treated group; 1.6-1.8-fold in the Epithalamin-treated group; 2.5-fold in the patients treated with Thymalin plus Epithalamin as compared to the control. A separate group of patients was treated with Thymalin in combination with Epithalamin annually for 6 years and their mortality rate decreased 4.1 times as compared to the control. CONCLUSIONS: The obtained data confirmed the high geroprotective efficacy of Thymalin and Epithalamin and the expediency of their application in medicine and social care for health maintenance and age-related pathology prevention in persons over 60 to prolong their active longevity. Ïîëíûé òåêñò ñòàòüè åñòü çäåñü: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Äëÿ ìåíÿ (íåñïåöèàëèñòà â ýòîé îáëàñòè) ðàáîòà âûãëÿäèò âïîëíå "íàó÷íî": 1. the trial was double blind (ñòð.236), 2. èñïîëüçîâàëèñü ïðåïàðàòû, çàðåãèñòðèðîâàííûå â êà÷åñòâå ëåêàðñòâåííûõ ñðåäñòâ (è ïåïòèäíûå ïðåïàðàòû ââîäèëèñü âíóòðèìûøå÷íî), 3. çà 6 ëåò íàáëþäåíèé çàôèêñèðîâàíî ñòàòèñòè÷åñêè çíà÷èìîå ñíèæåíèå çàáîëåâàåìîñòè è ñìåðòíîñòè ïî ñðàâíåíèþ ñ êîíòðîëüíîé ãðóïïîé (äî p<0.001), 4. ñõîäíûå ðåçóëüòàòû ïîëó÷åíû è â äðóãîì èíñòèòóòå. Åñëè íå ïðåäïîëàãàòü ôàëüñèôèêàöèþ, îòìàõíóòüñÿ îò òàêîãî ðåçóëüòàòà òðóäíî.  òî æå âðåìÿ çàïóùåííàÿ ñåé÷àñ êîìïàíèÿ ïî ïîäîáíûì ïðåïàðàòàì èìååò ìíîãî ñîìíèòåëüíûõ ÷åðò, õîòÿ èäåò êàê-áóäòî èç òîãî æå èñòî÷íèêà., è ýòî ñìóùàåò.  ýòîé ñâÿçè ìíå, êàê è ðàíåå Avart-ó, õîòåëîñü áû óçíàòü ìíåíèå ïðîôåññèîíàëîâ ïî äàííîé òåìàòèêå. Íàäåþñü, ÷òî ññûëêà íà êîíêðåòíóþ ðàáîòó ñäåëàåò îáñóæäåíèå áîëåå ïðåäìåòíûì. |
#10
|
||||
|
||||
À òåïåðü ó÷èìñÿ ñòðÿõèâàòü ëàïøó ñ óøåé - ñì Òðèøà Ãðèíõàëüõ "Ïóòåâîäèòåëü ÷èòàòåëÿ ìåäèöèíñêîé ëèòåðàòóðû"
È âîîáùå ïðèíîñèì ññûëêè òîëüêî íà ïðèëè÷íûå ðàáîòû
__________________
Ã.À. Ìåëüíè÷åíêî |
#11
|
|||
|
|||
Go to #4
|
#12
|
|||
|
|||
Íó, õîðîøî åù¸, íå go to 3 áóêâû.
Ïîçèöèÿ , ïðèìåðíî, ïîíÿòíà: ÁÀÄ = ëîõîòðîí; Ëåêàðñòâî - êîíêðåòíîå çàáîëåâàíèå - ýôôåêò. À êàê íàñ÷¸ò ïðîôèëàêòè÷åñêîé ìåäèöèíû? Ãåðîíòîëîãèþ Âû ïîñûëàåòå òóäà æå êóäà è ÁÀÄ? Ïîëó÷àåòñÿ âñå ïîñåòèòåëè - íå âðà÷è - ïî îïðåäåëåíèþ ëîõè, è äîëæíû go to #4. Çíàåòå ÿ ïðîñìàòðèâàë â èíåòå êîíôåðåíöèþ äëÿ æóðíàëèñòîâ (2008ã.), ïîñâÿù¸ííóþ ïåïòèäàì - òàì áûë äîâîëüíî ïðåäñòàâèòåëüíûé äåñàíò äîêëàä÷èêîâ, â òîì ÷èñëå, àêàäåìèêîâ è ÷ëåí-êîððåñïîíäåíòîâ ÐÀÌÍ. ß ïîíèìàþ, ÷òî ýòî ÏÈÀÐ, íî ÏÈÀÐ ïðåäñòàâèòåëüíûé, êàê áû îñâÿùåííûé àâòîðèòåòîì ÐÀÌÍ. ß ÷èòàë è äðóãèå èõ ìàòåðèàëû íà ýòó òåìó, ÿ âëåç â áèîõèìèþ ÷åëîâåêà Ìàððè è Ãðåííåðà, è óâèäåë, ÷òî äåéñòâèòåëüíî èìåþòñÿ ãîðìîíû ïåïòèäíîé ïðèðîäû è ïîýòîìó, ãèïîòåòè÷åñêè, ðåãóëÿöèîííûé ïîäõîä ñ èñïîëüçîâàíèåì ïåïòèäîâ èñêóññòâåííîé ïðèðîäû âðîäå áû âîçìîæåí - íó à îñòàëüíîå óæå äåëî äîáðîñîâåñòíîñòè èññëåäîâàòåëÿ. Ñêàæåì, íà êîíôåðåíöèè ïðîçâó÷àë âîïðîñ - ïðîâîäèëèñü ëè èññëåäîâàíèÿ íà ïàöèåíòàõ äâîéíûì ñëåïûì ìåòîäîì. Îòâåò òî÷íî íå ïîìíþ, ïðèìåðíî - â äàííîé ñèòóàöèè íàïðÿìóþ îí íåïðèìåíèì, íî èññëåäîâàíèÿ ïðîâîäèëèñü ìàêñèìàëüíî ïðèáëèæ¸ííî. Åù¸ îäèí ïðîçâó÷àâøèé âîïðîñ - ïåïòèäû - ýòî ÁÀÄû? Îòâåò - ôîðìàëüíî - äà, à ïî ñóòè - íåò. Òåïåðü âîïðîñû: 1. Âîçìîæíî ëè ãèïîòåòè÷åñêè ïðèìåíåíèå èñêóññòâåííûõ ðåãóëÿòîðíûõ ïåïòèäîâ äëÿ öåëåíàïðàâëåííîãî îçäîðîâëåíèÿ ÷åëîâåêà? 2. Ïîñêîëüêó Âû óæå âûñêàçàëèñü ïî ñóùåñòâó êîíêðåòíûõ ïåïòèäîâ - òî, âñ¸ æå, â ÷¸ì èõ íåïðàâîòà? Òåîðåòè÷åñêè è ïðàêòè÷åñêè. Íàïîìèíàþ, íà #4 ÿ óæå áûë. |
#13
|
|||
|
|||
Öèòàòà:
Íà ñàìîì äåëå, íóæíî áû îòâå÷àòü òàê: ôîðìàëüíî - äà, è ÷òî èç ýòîãî? |
#14
|
|||
|
|||
Ïðîäåìîíñòðèðóéòå ïðèìåð ïðîôèëàêòè÷åñêîé ìåäèöèíû â Âàøåì ïîíèìàíèè. Òà æå ïðîñüáà îòíîñèòåëüíî ãåðîíòîëîãèè.
È ïåðå÷èòàéòå ïîñò ¹4. Ïðè îòñóòñòâèè ïîíèìàíèÿ íàì ïðèäåòñÿ ðàññòàòüñÿ. |
#15
|
|||
|
|||
|